Telitacicept
RC18G007
Phase 3 mab active
Quick answer
Telitacicept for Primary Sjogren's Disease is a Phase 3 program (mab) at Vor Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vor Biopharma
- Indication
- Primary Sjogren's Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- active